Orthopaedic Industry News & Orthopaedic Company News | Orthogate Professionals

Accounting for US$ 105 Mn revenue share, whereas, Western Europe is expected to register 18.5% CAGR over the forecast period.

VALLEY COTTAGE, NEW YORK, UNITED STATES, December 13, 2016 /EINPresswire.com/ -- Future Market Insights delivers key insights on the global 3D printed medical devices market in a new publication titled “3D Printed Medical Devices Market: Global Industry Analysis and Opportunity Assessment, 2016 – 2026”. The global 3D printed medical devices market was estimated to be US$ 238 Mn in 2015 and it has a wide scope of growth in the forecast period. The global 3D printed medical devices market can be broadly classified into six segments depending on the technology namely – stereolithography (SLA), selective layer sintering (SLS), digital light processing (DLP), fused deposition modelling (FDM), polyjet / inkjet 3D printing, and electronic beam melting (EBM) – each with different applications that are specific to orthopaedic, dental, and internal and external prosthetics.

Transparency Market Research Report Added "Drug Device Combination Products Market - Global Industry Analysis, Trends and Forecast 2013 - 2019"

The global market for drug device combination products was worth US$87.1 bn in 2015 and it is predicted to be worth US$115.1 bn in 2019.

Download Complete Healthcare Industry Analytical Brochure:

www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_ ..

The global drug device combination products market is a consolidated one with a few well-entrenched companies dominating it. The competition in the market is predicted to heat up further in the near future on account of players channelizing their energies into research and development of products with innovative technologies and improved functionality.

After four years of negotiation, the European Parliament has published the text of its EU Medical Device Regulation (MDR), setting the stage for sweeping changes across the medical device value chain.

As expected, medtechs will bear the brunt of the costs of complying with the new regulation. To reduce the costs - and execution hazards - associated with implementation, we recommend companies take a risk-based approach to compliance that involves a detailed assessment of the revenue impact, as well as the cost and complexity of remediation. By outlining a thoughtful, well-ordered approach now, medtechs can protect valuable and future revenues while making upgrades to critical business functions.

Here are three highlights:

1. The global orthopedic devices market is anticipated to reach $47.5 billion by 2022.

2. Smaller companies introducing novel products are driving market growth.

3. To remain competitive in the space, manufacturers must offer devices with more advanced technology.

More articles on devices:
Flexion Therapeutics submits new drug application for knee osteoarthritis pain pill: 4 key notes
Global hip, knee implant market to hit $33B by 2022: 5 observations
SeaSpine names William Rhoda to new executive position: 5 things to know

Here are five observations:

1. In 2015, 325,000 people underwent total hip replacement surgery in the Untied States.

2. Computer assistance represents a new trend in the total hip replacement surgery field.

3. The increasing aging population is driving the market.

4. Warsaw, Ind.-based Zimmer Biomet leads the hip and knee orthopedic implant market, offering its ML taper hip prosthesis with Kinectiv modular neck technology.

5. Other market leaders include:

• DePuy Synthes in West Chester, Pa.

Here are five insights:

1. Of the seven firms covering the company's stock, three rated it as "sell," three gave it a "hold" and three offered a "buy" rating.

2. Analysts gave Mazor Robotics an average 12-month price target of $27.67.

3. Mazor Robotics possesses a 50-day moving average of $22.68 and a 200-day moving average of $20.80.

4. The company's market capitalization is $529.2 million.

5. With a one-year low of $8.31, the company has a one-year high of $26.55.

Here are four takeaways:

1. Initia features Kyocera Medical's BIOCERAM AZU zirconia-toughened alumina ceramic femoral heads.

2. Surgeons may also purchase the system with cobalt chrome femoral heads, which are matched to cross-linked polyethylene acetabular liners.

3. The system is available in 16 taper-wedge stem sizes, with 12 of those available in the United States.

4. Kyocera Medical manufactures implantable systems and advanced ceramic components.

More articles on devices:
Aurora Spine, Zimmer Biomet, DePuy Synthes & more: 11 key notes

Here are five highlights:

1. The HoloLens guides surgeons to more accurately place pedicle screws.

2. The device is also intended to help surgeons avoid complications, like neural damage or implant loosening, by providing proper pedicle screw placement.

3. The HoloLens offers a 3-D CT scan, which provides a trajectory for screw placement.

4. Dr. Henrique Lampert and Dr. Bruno Gobbato, of the Instituto de Ortopedia e Traumatologia de Jaraguá do Su, have used the device.